163 related articles for article (PubMed ID: 27161966)
1. Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial.
Warris LT; van den Heuvel-Eibrink MM; Aarsen FK; Pluijm SM; Bierings MB; van den Bos C; Zwaan CM; Thygesen HH; Tissing WJ; Veening MA; Pieters R; van den Akker EL
J Clin Oncol; 2016 Jul; 34(19):2287-93. PubMed ID: 27161966
[TBL] [Abstract][Full Text] [Related]
2. Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design.
van Hulst AM; Verwaaijen EJ; Fiocco MF; Pluijm SMF; Grootenhuis MA; Pieters R; van den Akker ELT; van den Heuvel-Eibrink MM
BMC Pediatr; 2021 Sep; 21(1):427. PubMed ID: 34579671
[TBL] [Abstract][Full Text] [Related]
3. Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design.
van Hulst AM; van den Akker ELT; Verwaaijen EJ; Fiocco M; Rensen N; van Litsenburg RRL; Pluijm SMF; Zwaan CM; van Santen HM; Pieters R; Evers AWM; Grootenhuis MA; van den Heuvel-Eibrink MM
Eur J Cancer; 2023 Jul; 187():124-133. PubMed ID: 37149961
[TBL] [Abstract][Full Text] [Related]
4. Predicting the neurobehavioral side effects of dexamethasone in pediatric acute lymphoblastic leukemia.
Warris LT; van den Akker EL; Aarsen FK; Bierings MB; van den Bos C; Tissing WJ; Sassen SD; Veening MA; Zwaan CM; Pieters R; van den Heuvel-Eibrink MM
Psychoneuroendocrinology; 2016 Oct; 72():190-5. PubMed ID: 27448086
[TBL] [Abstract][Full Text] [Related]
5. Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design.
Zhang D; Gu M
Eur J Cancer; 2023 Sep; 191():112979. PubMed ID: 37532597
[No Abstract] [Full Text] [Related]
6. Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design.
van Hulst AM; Grootenhuis MA; van den Akker ELT; van den Heuvel-Eibrink MM
Eur J Cancer; 2023 Sep; 191():112980. PubMed ID: 37574396
[No Abstract] [Full Text] [Related]
7. Does dexamethasone induce more neuropsychological side effects than prednisone in pediatric acute lymphoblastic leukemia? A systematic review.
Warris LT; van den Heuvel-Eibrink MM; den Hoed MA; Aarsen FK; Pieters R; van den Akker EL
Pediatr Blood Cancer; 2014 Jul; 61(7):1313-8. PubMed ID: 24532490
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia.
Hinds PS; Hockenberry MJ; Gattuso JS; Srivastava DK; Tong X; Jones H; West N; McCarthy KS; Sadeh A; Ash M; Fernandez C; Pui CH
Cancer; 2007 Nov; 110(10):2321-30. PubMed ID: 17926333
[TBL] [Abstract][Full Text] [Related]
9. The DEXA-CORT trial: study protocol of a randomised placebo-controlled trial of hydrocortisone in patients with brain tumour on the prevention of neuropsychiatric adverse effects caused by perioperative dexamethasone.
Koning ACAM; Satoer DD; Vinkers CH; Zamanipoor Najafabadi AH; Biermasz NR; Nandoe Tewarie RDS; Moojen WA; van Rossum EFC; Dirven CMF; Pereira AM; van Furth WR; Meijer OC
BMJ Open; 2021 Dec; 11(12):e054405. PubMed ID: 37057711
[TBL] [Abstract][Full Text] [Related]
10. The effects of dexamethasone on sleep in young children with acute lymphoblastic leukemia.
Rosen G; Harris AK; Liu M; Dreyfus J; Krueger J; Messinger YH
Sleep Med; 2015 Apr; 16(4):503-9. PubMed ID: 25799940
[TBL] [Abstract][Full Text] [Related]
11. HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL).
Eiser C; Davies H; Jenney M; Stride C; Glaser A
Pediatr Blood Cancer; 2006 Jan; 46(1):35-9. PubMed ID: 15926164
[TBL] [Abstract][Full Text] [Related]
12. Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone.
Warris LT; van den Akker EL; Bierings MB; van den Bos C; Zwaan CM; Sassen SD; Tissing WJ; Veening MA; Pieters R; van den Heuvel-Eibrink MM
PLoS One; 2016; 11(6):e0158225. PubMed ID: 27362350
[TBL] [Abstract][Full Text] [Related]
13. The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia.
Kunin-Batson A; Kadan-Lottick N; Neglia JP
Psychooncology; 2014 Jun; 23(6):692-9. PubMed ID: 24497266
[TBL] [Abstract][Full Text] [Related]
14. Unraveling Dexamethasone-Induced Neurobehavioral and Sleep Problems in Children With ALL: Which Determinants Are Important?
van Hulst AM; Grootenhuis MA; Verwaaijen EJ; van Litsenburg RRL; Li L; van Zelst BD; Broer L; Pluijm SMF; Pieters R; Fiocco M; van den Akker ELT; van den Heuvel-Eibrink MM
JCO Precis Oncol; 2023 Jun; 7():e2200678. PubMed ID: 37343203
[TBL] [Abstract][Full Text] [Related]
15. Duration of adrenal insufficiency during treatment for childhood acute lymphoblastic leukemia.
Vestergaard TR; Juul A; Lausten-Thomsen U; Lausen B; Hjalgrim H; Kvist TK; Andersen EW; Schmiegelow K
J Pediatr Hematol Oncol; 2011 Aug; 33(6):442-9. PubMed ID: 21792040
[TBL] [Abstract][Full Text] [Related]
16. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
17. The impact of maintenance therapy on sleep-wake rhythms and cancer-related fatigue in pediatric acute lymphoblastic leukemia.
Steur LMH; Kaspers GJL; van Someren EJW; van Eijkelenburg NKA; van der Sluis IM; Dors N; van den Bos C; Tissing WJE; Grootenhuis MA; van Litsenburg RRL
Support Care Cancer; 2020 Dec; 28(12):5983-5993. PubMed ID: 32285260
[TBL] [Abstract][Full Text] [Related]
18. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
Einaudi S; Bertorello N; Masera N; Farinasso L; Barisone E; Rizzari C; Corrias A; Villa A; Riva F; Saracco P; Pastore G
Pediatr Blood Cancer; 2008 Mar; 50(3):537-41. PubMed ID: 17828747
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of adrenal reserve in children with acute lymphocytic leukemia treated with prednisone or dexamethasone.
Kuperman H; Odone Filho V; Cristofani LM; Assis de Almeida MT; Setian N; Damiani D
Horm Res Paediatr; 2012; 78(2):73-80. PubMed ID: 22922775
[TBL] [Abstract][Full Text] [Related]
20. TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial.
Klaassen ILM; Lauw MN; van de Wetering MD; Biemond BJ; Middeldorp S; Abbink FCH; Bierings M; Te Loo DMMW; Pieters R; van der Sluis IM; Tissing WJE; Michel Zwaan C; Heleen van Ommen C
BMC Pediatr; 2017 May; 17(1):122. PubMed ID: 28486976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
